Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dental Products Panel okays use of Colgate Total in children with label disclosure.

This article was originally published in The Tan Sheet

Executive Summary

DENTAL PRODUCTS PANEL OKAYS COLGATE TOTAL USE IN CHILDREN as long as the labeling of the triclosan toothpaste discloses that efficacy in children has not been established. On Feb. 29, FDA's Dental Products Panel and some members of the Dental Drug Products Plaque Subcommittee reviewed Colgate-Palmolive's NDA for its Total toothpaste, clearing the anti-plaque, anti-gingivitis and anti-caries dentifrice containing triclosan .3% and sodium fluoride .24% for approval .

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel